SCHEMBL5501376

SCHEMBL5501376

COc1cc2c(Oc3ccccc3)ncnc2cc1OCCN1CCCC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 14/20 0.66
FLT4 P35916 13/20 0.66
PDGFRB P09619 5/20 0.66
AURKA O14965 3/20 0.66
TEK Q02763 3/20 0.66
AURKB Q96GD4 3/20 0.66
CSF1R P07333 3/20 0.62
FLT3 P36888 3/20 0.62
FLT1 P17948 9/20 0.60
BRAF P15056 2/20 0.58
EPHB4 P54760 3/20 0.57
EGFR P00533 2/20 0.57
PLK4 O00444 1/20 0.57
GAK O14976 1/20 0.57
EPHB6 O15197 1/20 0.57
RIPK2 O43353 1/20 0.57
ERN1 O75460 1/20 0.57
STK10 O94804 1/20 0.57
MAP4K4 O95819 1/20 0.57
CHEK2 O96017 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4377465 0.99 KDR (0.65) KDRFLT4PDGFRBAURKATEK
SCHEMBL7211076 0.93 KDR (0.66) KDRFLT4PDGFRBAURKATEK
SCHEMBL19258467 0.91 AURKA (0.62) KDRFLT4PDGFRBAURKATEK
SCHEMBL7209933 0.91 AURKA (0.59) KDRFLT4PDGFRBAURKATEK
SCHEMBL7209612 0.91 EGFR (0.62) KDRFLT4PDGFRBAURKATEK
SCHEMBL30408124 0.90 FLT4 (0.61) KDRFLT4PDGFRBAURKATEK
SCHEMBL20547607 0.90 FLT4 (0.61) KDRFLT4PDGFRBAURKATEK
SCHEMBL23720684 0.88 FLT4 (0.60) KDRFLT4PDGFRBAURKATEK
SCHEMBL19258107 0.88 KDR (0.73) KDRFLT4PDGFRBAURKATEK
SCHEMBL17278101 0.86 SRC (0.66) KDRFLT4PDGFRBAURKATEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1005470-B1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ASTRAZENECA AB (SE) 2007-08-01 EP disclosed
EP-0880508-B1 QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS ASTRAZENECA AB (SE) 2003-04-16 EP disclosed
US-6294532-B1 TREATMENT OF A NUMBER OF DISEASE STATES INCLUDING CANCER AND RHEUMATOID ARTHRITIS. ZENECA LIMITED (GB) 2001-09-25 US disclosed
US-6184225-B1 ENDOTHELIAL GROWTH FACTOR INHIBITORS, ANGIOGENESIS INHIBITORS ZENECA LIMITED (GB) 2001-02-06 US disclosed
EP-1005470-A1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ZENECA LIMITED (GB) 2000-06-07 EP disclosed
WO-1999010349-A1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ZENECA LIMITED (GB) 1999-03-04 WO disclosed
EP-0880508-A1 QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS ZENECA LIMITED (GB) 1998-12-02 EP disclosed
WO-1997030035-A1 QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS ZENECA LIMITED (GB) 1997-08-21 WO disclosed